November marks Lung Cancer Awareness Month, a time dedicated to raising awareness about the leading cause of cancer-related deaths worldwide. This initiative aims to educate the public about the risks, prevention, and available treatments for lung cancer.
Despite significant advancements in medical research, lung cancer is responsible for approximately 2 million deaths each year, making awareness efforts crucial in the fight against this formidable disease.
Lung cancer affects both smokers and non-smokers, emphasizing the importance of understanding all risk factors. Early detection plays a pivotal role in improving survival rates, making it essential for individuals to be aware of the symptoms, which can often be subtle and overlooked. Symptoms could include coughing that gets worse or doesn’t go away, chest pain, shortness of breath, wheezing, coughing up blood.
Fortunately, medical science has made significant strides in lung cancer treatment. The approach to managing this disease varies based on the type and stage of cancer. Common treatment options include surgery, chemotherapy, radiation therapy, and palliative care. Personalized treatment plans have shown promising results, offering hope to those diagnosed with lung cancer.
GCT is taking an active part in cancer treatment and is an expert in conducting Oncology clinical trials. Please contact us at bd@gctrials.com to learn more about our experience.